EUVIMED · CrossrefJournal
NAM Journal
ISSN 3050-6204 · Elsevier BV
Latest articles
Promoting co-creation and flexibility in transdisciplinary research projects on alternatives - the agile approach of the Virtual Human Platform for Safety Assessment project
Decarbonizing Preclinical Research: Sustainability Benefits of Caenorhabditis elegans as a Non-Animal Alternative to Rodent Testing
Enabling NAMs-based bioaccumulation assessment: EPAA recommendations in support of the EU “Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments"
Implementation of NAMs for Endocrine Disruptors Through Collective Action
Liver sinusoidal endothelial cell-conditioned media promote Kupffer cell-associated features in THP-1-derived macrophages
Report of collaboration to harmonise the assessment of next generation evidence (CHANGE) 2nd workshop in Oslo, June 24 - 26, 2025 – participants perspectives on the Change working methodology
Investigations into the biological activity of avobenzone as part of a Next Generation Risk Assessment
A case study with benzoic acid demonstrating how integration of In Silico Tools, mechanistic In Vitro NAM, and toxicological data improves definition of point of departure for a chemically defined class in read-across assessments
Never-ending Acronym Madness: Proposing a harmonized definition for NAMs
3Rs at the European Medicines Agency: Past and future activities
Engineering ethical test systems: Tissue-engineered and in vitro alternatives to in vivo experiments
MicroRNA network regulation of developmental bone toxicity in a human embryonic stem cell osteogenic model
Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure
A human tracheobronchial epithelial tissue airway injury and remodeling (hTET-AIR) NAM for assessing epithelial pathology: From goblet cell hyperplasia to squamous metaplasia
Microfluidics-based multi-endpoint assessment of reproductive toxicity in C. elegans in response to heavy metal exposure
Development of machine learning models to predict chemical-induced ocular irritation
REACH revision: if not now, what can we do for modernising chemical safety assessment?
Towards replacement of animal experimentation in scientific research and regulatory testing: launch of NAM Journal
New frontiers in anti-cancer drug testing: The need for a relevant In vitro testing model
Exploring animal methods bias in biomedical research funding: Workshop proceedings and action steps
Development of in silico models that define the applicability domains of binary classifiers: An ITSv2-defined approach for identifying skin sensitization hazards
A systematic approach towards long-term, serum-free cultivation of fish cells with the RTgill-W1 cell line as example
Highlighting best practices to advance next-generation risk assessment of cosmetic ingredients
Complement-ARIE: Catalyzing the development and adoption of new approach methodologies
Panel discussions on the global regulatory acceptance and harmonisation of non-animal NAMs
Botulinum neurotoxin: Tracking the transition from lethal dose to in vitro models
A survey to evaluate animal methods bias experienced by India-based researchers in the peer review of manuscripts and grant applications
Qualitative and quantitative evaluation of Fetal Bovine Serum composition: toward ethical and best quality in vitro science
Pursuing societal impact in research projects on NAM development: An analysis of routes to impact
Next-generation non-animal models for inflammatory bowel disease: In vitro and in silico approaches for mechanistic understanding
EUVIMED